Specify a stock or a cryptocurrency in the search bar to get a summary
NIGHTINGALE HEALTH EO 1
7XENightingale Health Oyj, a health technology company, offers health data platform that detects disease risks. The company's blood analysis technology measures various biomarkers from a single blood sample and identifies personal risks of disease using health data assets. It serves healthcare industry and researchers in Finland, the United Kingdom, rest of Europe, and internationally. The company has research collaboration agreement with ZOE Limited for its blood collection device. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland. Address: Mannerheimintie 164a, Helsinki, Finland, 00300
Analytics
WallStreet Target Price
1.17 EURP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 7XE
Dividend Analytics 7XE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 7XE
Stock Valuation 7XE
Financials 7XE
Results | 2019 | Dynamics |